COVID-19 Vaccine: India’s DGCI waives post-approval bridging trials for Pfizer, Moderna - Job Community
ads
Responsive Ads Here

Post Top Ad

Your Ad Spot

Wednesday, 2 June 2021

Home Current Affairs Jagran Josh COVID-19 Vaccine: India’s DGCI waives post-approval bridging trials for Pfizer, Moderna

COVID-19 Vaccine: India’s DGCI waives post-approval bridging trials for Pfizer, Moderna

The Drug Controller General of India (DGCI) waives the requirement for foreign companies to conduct post-launch bridging trials here in the country. Read all you need to know.



from Jagran Josh https://ift.tt/3yV9eTM
Tags
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Post Top Ad

Your Ad Spot